Preprint Review Version 1 Preserved in Portico This version is not peer-reviewed

Advances in Understanding Fibrosis: Mechanisms, Clinical Implications, Current Therapies, and Prospects for Future Interventions

Version 1 : Received: 28 June 2023 / Approved: 29 June 2023 / Online: 29 June 2023 (14:13:43 CEST)

A peer-reviewed article of this Preprint also exists.

Ku, J.C.; Raiten, J.; Li, Y. Understanding Fibrosis: Mechanisms, Clinical Implications, Current Therapies, and Prospects for Future Interventions. Biomedical Engineering Advances 2024, 100118, doi:10.1016/j.bea.2024.100118. Ku, J.C.; Raiten, J.; Li, Y. Understanding Fibrosis: Mechanisms, Clinical Implications, Current Therapies, and Prospects for Future Interventions. Biomedical Engineering Advances 2024, 100118, doi:10.1016/j.bea.2024.100118.

Abstract

Fibrosis is a prevalent and detrimental condition associated with various diseases with a high impact on global morbidity and mortality rates. Despite its diverse causes and affected organs, common underlying mechanisms drive the development and progression of the disease. These mechanisms include an exaggerated inflammatory response, excessive activation of fibroblasts, and abnormal tissue remodeling following severe or repetitive tissue injury. Although significant advancements have been achieved to enhance our understanding of fibrosis, there is still a gap between identifying potential antifibrotic targets and successfully translating them into effective clinical interventions. Novel approaches that target specific cellular and molecular processes involved in fibrosis hold promise for reducing the pathological consequences of the disease. Understanding the pathogenesis and clinical implications of fibrotic diseases is crucial for developing effective therapeutic strategies and improving patient outcomes. In this review, we introduce the concept of fibrosis, discuss the mechanisms by which it arises, and explore existing and emerging therapeutic approaches in development.

Keywords

fibrosis; inflammatory; fibroblasts; extracellular matrix; therapeutic strategy

Subject

Medicine and Pharmacology, Medicine and Pharmacology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.